Management of Pain in Lumbar Arthrodesis

• Status: Recruiting
• Trial end date: 2025-12-31
• Target enrollment: 0
• Participant gender: All

Summary

KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dexamethasone administration perioperatively in patients undergoing lumbar arthrodesis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
• Treatments: Dexamethasone; Ketamine

Criteria

Inclusion Criteria:

• Male or female

• Age> 18 years

• ASA I-III.

• Lumbar arthrodesis.

• Patients who have signed the preoperative informed consent for participation in the study.

Exclusion Criteria:

• Unstable coronary heart disease

• Glaucoma

• History of allergy to ketamine, dexamethasone, or morphic chloride

• Dementia or inability to understand IC and study

• Pluricomplicated diabetes mellitus difficult to control

• Patients who have taken an experimental drug 30 days before the start of the study or who are included in any type of study of an experimental drug